D311 Microbiology - Set 2 - Part 3

Correct Answer: Autoclaving

Option a is correct because autoclaving uses pressurized steam at one hundred twenty-one degrees Celsius to denature all proteins, including endospores. It is the gold standard sterilization method for heat-stable surgical instruments and laboratory materials. Option b is incorrect because dry-heat sterilization uses hot, dry air at much higher temperatures for longer periods without steam or pressure. The scenario specifies pressurized steam, which defines autoclaving rather than dry-heat methods. Option c is incorrect because HEPA filtration removes microorganisms from air and heat-sensitive liquids by mechanical size exclusion through fine filters. It cannot sterilize solid metal instruments and does not use heat or pressure. Option d is incorrect because gamma irradiation uses ionizing radiation to sterilize heat-sensitive items such as single-use devices or food. The scenario describes pressurized steam at a specific temperature and time, which specifically defines autoclaving.

Correct Answer: Antiseptic

Option c is correct because antiseptics are antimicrobial agents formulated to be safe for direct application to living skin and mucous membranes. Iodophors, chlorhexidine, and hydrogen peroxide are common antiseptics used in clinical settings. Option a is incorrect because sterilants destroy all forms of microbial life including spores on inanimate objects. They are far too chemically aggressive for application to living tissues and are not classified as antiseptics. Option b is incorrect because bacteriostatic agents inhibit bacterial growth without killing organisms outright. This describes a drug mechanism of action rather than a tissue-safety classification defining whether an agent can be applied to living surfaces. Option d is incorrect because sanitizers reduce microbial contamination on inanimate surfaces to acceptable public health levels. They are used for surface decontamination, not for direct application to living tissues as antiseptics are designed for.

Correct Answer: Drug modification or inactivation

Option d is correct because drug modification or inactivation occurs when bacteria produce enzymes that chemically destroy antibiotics before they reach their target. Beta-lactamases cleave the beta-lactam ring of penicillins, rendering them inactive. Option a is incorrect because target modification involves altering the antibiotic's binding site so the drug cannot attach effectively. The scenario describes enzymatic destruction of the antibiotic molecule itself, not changes to the drug's cellular target. Option b is incorrect because efflux pumps remove intact antibiotics from inside bacterial cells before they accumulate to effective levels. The scenario describes enzymatic drug destruction before target contact, not active membrane-based drug expulsion. Option c is incorrect because target overproduction involves producing excessive copies of the drug's target to overwhelm antibiotic effects. The scenario describes enzymatic drug destruction before any target contact

Correct Answer: Bactericidal antibiotic

Option b is correct because bactericidal antibiotics directly kill bacteria rather than inhibiting their growth. Immunocompromised patients who lack sufficient immune function to clear stalled infections require bactericidal drugs that can eliminate pathogens independently. Option a is incorrect because narrow-spectrum describes the limited range of organisms an antibiotic targets. Spectrum classification describes breadth of coverage, not whether the drug kills bacteria directly or merely slows their replication. Option c is incorrect because broad-spectrum describes antibiotics effective against a wide range of bacterial species. Spectrum classification describes coverage breadth rather than whether a drug kills bacteria outright or only inhibits their growth. Option d is incorrect because bacteriostatic antibiotics inhibit bacterial growth without killing organisms, requiring an intact immune system to clear stalled pathogens. This makes them inappropriate for the severely immunocom

Correct Answer: Methicillin-resistant Staphylococcus aureus

Option a is correct because MRSA carries the mecA gene, which encodes an altered penicillin-binding protein resistant to all beta-lactam antibiotics. It commonly causes hospital-acquired surgical site infections and requires vancomycin treatment. Option b is incorrect because vancomycin-resistant Enterococcus resists glycopeptides through modified cell wall precursors rather than through altered penicillin-binding proteins. The resistance mechanism and drug class targeted in the scenario do not match VRE. Option c is incorrect because carbapenem-resistant Klebsiella is gram-negative and resists carbapenems through carbapenemase production or porin loss. The scenario describes a gram-positive organism with an altered penicillin-binding protein, which is inconsistent with Klebsiella. Option d is incorrect because ESBL E. coli is gram-negative and uses hydrolytic enzyme production to resist beta-lactams. The gram-positive organism with an altered penicillin-binding protein described in th

Correct Answer: Cellular immunity

Option c is correct because cellular immunity is mediated by cytotoxic T lymphocytes that recognize and kill host cells presenting intracellular pathogen antigens on MHC class I molecules, eliminating pathogens that circulating antibodies cannot reach. Option a is incorrect because innate immunity is the non-specific, immediate defense system lacking memory and pathogen-specific recognition. The question describes an arm of adaptive immunity requiring antigen-specific lymphocyte activation, not innate immune responses. Option b is incorrect because humoral immunity describes the antibody-secreting B lymphocyte arm already referenced in the question. The question asks about the second arm that uses T lymphocytes to destroy infected cells presenting antigen. Option d is incorrect because complement activation is an innate immune protein cascade triggered by microbial surfaces or antibody complexes. It is not an adaptive immune arm deploying antigen-specific lymphocytes to destroy infecte

Correct Answer: Live attenuated vaccine

Option d is correct because live attenuated vaccines contain weakened living pathogens that replicate in the host, generating strong, long-lasting immunity. MMR and varicella vaccines are examples but are contraindicated for immunocompromised individuals. Option a is incorrect because inactivated vaccines contain killed pathogens that cannot replicate. They typically produce weaker immunity requiring booster doses and are safe for immunocompromised patients because the pathogen cannot proliferate after injection. Option b is incorrect because subunit vaccines contain only specific pathogen components like purified proteins, not whole organisms. They are safe for immunocompromised individuals because no living or intact pathogen is present in the formulation. Option c is incorrect because toxoid vaccines contain inactivated bacterial toxins chemically treated to be harmless. Examples include tetanus and diphtheria vaccines. They do not contain whole pathogens, weakened or otherwise.

Correct Answer: mRNA vaccine

Option b is correct because mRNA vaccines deliver pathogen protein-encoding messenger RNA into host cells, which temporarily produce the antigen. The immune system builds memory against this protein without the mRNA ever integrating into the host genome. Option a is incorrect because live attenuated vaccines contain whole weakened pathogens that replicate inside the host. They do not deliver individual genetic instructions for producing a single pathogen protein as mRNA vaccines do. Option c is incorrect because toxoid vaccines contain inactivated bacterial toxins chemically treated to be harmless. They immunize against toxin effects rather than delivering genetic instructions to direct host cells to produce pathogen proteins temporarily. Option d is incorrect because conjugate vaccines link polysaccharide antigens to carrier proteins to enhance immunogenicity in young children. They contain preformed protein-antigen complexes, not genetic instructions for directing host cell antigen p

Correct Answer: Herd immunity

Option a is correct because herd immunity occurs when enough of a population is immune to break transmission chains, protecting unvaccinated individuals including newborns and immunocompromised people. The required threshold varies by pathogen transmissibility. Option b is incorrect because passive immunity involves receiving preformed antibodies from an external source rather than the immune system generating its own response. It is temporary and individual rather than a community-level transmission-blocking phenomenon. Option c is incorrect because cross-protection describes immunity from one pathogen strain providing partial protection against a related strain through shared antigens. It describes individual immunological breadth, not community-level protection through reduced transmission chains. Option d is incorrect because active artificial immunity describes an individual's immune response to vaccination. It refers to personal immunity acquisition rather than the community

Correct Answer: Toxoid vaccine

Option c is correct because toxoid vaccines contain inactivated bacterial toxins that are harmless but retain their immunogenic structure. Tetanus and diphtheria vaccines stimulate antibody production that neutralizes the toxin during actual infection. Option a is incorrect because subunit vaccines contain specific purified pathogen proteins or polysaccharides rather than toxins. They target structural pathogen components rather than the secreted toxins that cause disease symptoms in the described scenario. Option b is incorrect because conjugate vaccines link polysaccharide antigens to carrier proteins to boost immunogenicity in young children. They are not made from inactivated toxins and target different pathogens than toxoid-preventable diseases like tetanus. Option d is incorrect because inactivated vaccines contain entire killed pathogens rather than isolated toxins. The scenario specifically describes a chemically neutralized secreted toxin formulated to build antibody protectio